Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. - Wikidata - awgldk - TriplyDB

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

http://www.wikidata.org/entity/Q37364811

about

cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)Pathways of Egr-1-mediated gene transcription in vascular biology Pharmacogenetics, pharmacogenomics and airway disease Association studies for asthma and atopic diseases: a comprehensive review of the literature Genetic polymorphisms in lung disease: bandwagon or breakthrough?Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies Emerging role of antileukotriene therapy in allergic rhinitis Genetic markers for differentiating aspirin-hypersensitivity G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells Gene variants in noncoding regions and their possible consequences.Cloning and functional analysis of the mouse 5-lipoxygenase promoter.Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.Prevalence of common disease-associated variants in Asian Indians.Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma.Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease.Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease Genetics and pulmonary medicine 8: asthma.Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.Association of Sp1 tandem repeat polymorphism of ALOX5 with coronary artery disease in Indian subjects The genetic basis of atopic asthma.Therapeutic strategies for allergic diseases.Genetic variations in the 5-lipoxygenase core promoter. Description and functional implications.Genetic mechanisms in aspirin-induced asthma.Antileukotriene therapy. Future directions.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma Asthma in sickle cell disease: implications for treatment.Association between Motilin Receptor Gene Haplotypes and Growth Traits in Japanese Hinai-dori Crossbred Chickens Genetics of aspirin induced asthma.Atopy and asthma genes--where do we stand?Leukotriene receptor antagonist therapy The lung HETEs (and EETs) up.Current treatment of asthma--focus on leukotrienes.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Severe asthma: definition and mechanisms.Genotyping the GGGCGG tandem repeat promoter polymorphism in the 5-lipoxygenase enzyme gene (ALOX5) by pyrosequencing assay.

P2860

Q24531306-8F7060EC-4E59-4FE2-A484-5A9BE08F20F4 Q24671655-AE4F3CBE-E661-41A8-BBCD-326B7AAAEB5D Q24798917-CDB9DCF0-B1EE-4818-B3E7-F175304A24C4 Q24802474-3502F835-FA73-4252-AB4B-05A7DB9B288E Q24807106-76910457-3D7C-4375-B2B1-C7DE20FEABF2 Q28067073-A1FBDA8E-4531-4CEF-834B-0159ED6DC06E Q28191844-91340540-75C0-4BB4-A1D2-73CDF04ADE28 Q28195398-0D8F5C8D-3786-41E7-B6A3-5810D3E6A57D Q28212087-229940C0-12D7-442F-BDE0-93D81A73C140 Q28222532-5F9E996E-BCF0-4447-969C-E63116DBB587 Q30413299-56D828A1-843A-4872-A100-C21B4DBD655A Q30439239-6C7584BA-5CE7-4282-8852-111511ACE484 Q30810336-CF7FA983-3486-431C-8636-3619452C7B55 Q31045753-B3629F37-BE57-494E-AE8D-C686D50006DE Q33227414-6ED2257E-B50B-466C-978C-F100426B767E Q33318138-1F876280-B9B9-4B44-A875-EDFB9E6EFC7D Q33325679-6B8ACEF0-D202-4493-BABD-AACD6FC3F6A4 Q33593217-0586D37C-A6A1-4B06-8C27-83275ED99BC1 Q33595339-FF55AE90-F795-4364-924D-89B741607C57 Q33622665-B07073BE-9F4B-4935-81C2-76115407618F Q33634172-2C7B96DA-E223-47C7-A40E-CC8314E159E9 Q33644748-1182BD87-469F-449E-92BF-B14DFADBA345 Q33677296-5A76022A-0E1A-4676-8A4C-993979060D7B Q33713314-638446A2-2707-4C67-B52F-3F9165079537 Q33717431-B51D23D2-7453-407C-81B1-E8FF70422684 Q33787614-C3FF71F2-E760-41E1-9181-A333CCDC5083 Q33836730-ACCE0D83-DB52-4A1A-B271-B75B48A3B8C5 Q33836776-4AC0F8B9-A4D8-4F70-89C4-27B7E5C2AB06 Q33836782-9AF1F86C-2C64-4A17-A6E2-17F7CDCFE453 Q33848692-7C582461-2788-4E9E-A846-359032290A12 Q33872120-E7AB87FE-B88B-44BB-B9C5-7A07A027E60E Q33885389-C222F7A3-84E1-4C2F-9135-5E903A1E23AD Q34036221-E2C2A089-5B38-4B1F-A905-63A55D90587C Q34044038-2260A5C4-8E7B-4F45-B870-082F6A3173ED Q34086351-D8E3A484-6CAC-4282-BCE3-98E8D4EF3715 Q34109234-2AD08DEF-5315-41C3-B269-DADCB63F9B1C Q34181970-4FC0C17A-959F-4C37-915D-020A8FE35566 Q34240729-9D821BFA-3AE1-438C-B41D-DE3DB1B1033F Q34364866-C7432724-89D9-4AB5-A269-B5595FD88297 Q34385384-B9273EEB-7A2C-445C-8A1D-428D9B09898C

P2860

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.

http://www.wikidata.org/entity/Q37364811

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 1997

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Naturally occurring mutations ...... d reporter gene transcription.

@en

Naturally occurring mutations ...... d reporter gene transcription.

@nl

type

label

Naturally occurring mutations ...... d reporter gene transcription.

@en

Naturally occurring mutations ...... d reporter gene transcription.

@nl

prefLabel

Naturally occurring mutations ...... d reporter gene transcription.

@en

Naturally occurring mutations ...... d reporter gene transcription.

@nl

P1433

Q37364811-6B4925F4-633F-4106-8964-DFF4C3BBD5D4

P1476

Q37364811-4780BAAE-30F8-4A83-95B8-677899235586

P2093

Q37364811-00B65E9B-1B56-42E8-9D75-03DEF88DA437

Q37364811-0BA96ABA-91F3-4F47-B9D8-E949751BC0B3

Q37364811-19423374-6ACE-409B-9E86-5EF3F8419E91

Q37364811-1AD993C8-2328-4E17-8BA7-9FE12605398D

Q37364811-2F89DB56-AE04-4BE9-9939-B0F359F058AA

Q37364811-363210A2-357B-490B-8428-7264D70A2EF1

Q37364811-39DC45EC-E655-487E-AF31-C129E2F9452D

Q37364811-3D123BC1-8128-4C44-8143-25DFC91FC62A

Q37364811-5DF9ADCF-49A7-4DEF-9AB0-CE2CCA920AEF

Q37364811-6058E411-A1D9-409F-A6B9-CEF2F0925123

P2860

Q37364811-0EBB3632-1D26-4820-ACE0-4C89D3F59E84

Q37364811-173D8598-EFB4-411C-9223-EBFD9A1618B1

Q37364811-18B35DFA-59BE-4CE4-9B53-72790A6C2DD7

Q37364811-1F3DA749-4368-41AD-98AE-928179DAACE5

Q37364811-2719E816-D44F-4D6A-9BD8-C726645E0782

Q37364811-5C752836-15D3-4180-91B0-5F993EB89B89

Q37364811-5FC35E17-2C9C-48A9-8E8B-4F73BA160953

Q37364811-64C04786-560B-4512-9398-8276D5CAA80B

Q37364811-73AE09BD-4823-4021-A2C9-AB4068B20349

Q37364811-77E2E438-9979-49F8-A790-B2AB9AD31E7D

P304

Q37364811-83EAD9DC-6076-4E57-8948-B3D6D3860999

P31

Q37364811-03ED192D-4559-4A91-844C-AD755EEAC05B

P356

Q37364811-8F823CC4-B025-4E65-A4BA-F2E9C2C3CCC9

P407

Q37364811-18FB5705-E54B-43A2-A14C-CCEB81F5EFE7

P433

Q37364811-3B93B3C2-4EAF-4F9B-9ADD-1D40DE1E3056

P478

Q37364811-8002753C-A6A1-4AF2-8E62-A75996FDFEC1

P577

Q37364811-1484E65C-EC3C-433A-98F1-64867E6546B8

P5875

Q37364811-BA5448FE-4B78-41B4-B6E2-5B2ED80774D1

P698

Q37364811-3951A7B7-CC78-4E9A-9BF2-C8BA5789C475

P932

Q37364811-0BA0DD71-59B8-490A-872D-2468C3E01B07

P356

P1433

Journal of Clinical Investigation

P1476

Naturally occurring mutations ...... d reporter gene transcription.

@en

P2093

Asano K

http://www.w3.org/2001/XMLSchema#string

Beier D

http://www.w3.org/2001/XMLSchema#string

Busse W

http://www.w3.org/2001/XMLSchema#string

Collins T

http://www.w3.org/2001/XMLSchema#string

De Sanctis GT

http://www.w3.org/2001/XMLSchema#string

Drazen JM

http://www.w3.org/2001/XMLSchema#string

Finn PW

http://www.w3.org/2001/XMLSchema#string

Fischer AR

http://www.w3.org/2001/XMLSchema#string

Grobholz J

http://www.w3.org/2001/XMLSchema#string

In KH

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human 5-lipoxygenase gene promoter

Characterization of the human 5-lipoxygenase gene

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction

Cytosine methylation does not affect binding of transcription factor Sp1

Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction

Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites.

P304

1130-1137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI119241

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

1997-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14150287

http://www.w3.org/2001/XMLSchema#string

P698

9062372

http://www.w3.org/2001/XMLSchema#string

P932

507922

http://www.w3.org/2001/XMLSchema#string